We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
+$684M
Cap. Flow
+$313M
Cap. Flow %
6.14%
Top 10 Hldgs %
29.02%
Holding
1,104
New
355
Increased
287
Reduced
198
Closed
246

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$115M
2
BHC icon
Bausch Health
BHC
+$84M
3
BKD icon
Brookdale Senior Living
BKD
+$72M
4
ABT icon
Abbott
ABT
+$56.3M
5
AET
Aetna Inc
AET
+$56.2M

Top Sells

Rank Stock Value
1
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
+$160M
2
PRGO icon
Perrigo
PRGO
+$122M
3
ENDP
Endo International plc
ENDP
+$115M
4
AMGN icon
Amgen
AMGN
+$82M
5
ESRX
Express Scripts Holding Company
ESRX
+$36.6M

Sector Composition

Rank Sector Weight
1 Healthcare 53.68%
2 Consumer Discretionary 6.01%
3 Consumer Staples 4.52%
4 Utilities 3.94%
5 Industrials 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEP icon
51
PepsiCo
PEP
$197B
$20.7M 0.41%
250,004
+1,247
+0.5% +$104K
NUS icon
52
Nu Skin
NUS
$253M
$20.2M 0.4%
146,205
-51,778
-26% -$6.1M
CADX
53
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$19.9M 0.39%
+2,200,000
New +$15.9M
NBIX icon
54
Neurocrine Biosciences
NBIX
$18.3B
$19.7M 0.39%
2,114,430
+307,293
+17% +$3M
VIRX
55
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$19.6M 0.38%
19,650
-6
-0% -$6.2K
QLTI
56
DELISTED
QLT Inc
QLTI
$19.4M 0.38%
3,480,000
+1,480,000
+74% +$7.33M
K
57
DELISTED
Kellanova
K
$18.7M 0.37%
326,414
+305,686
+1,475% +$17.6M
ENZY
58
DELISTED
Enzymotec Ltd
ENZY
$18.6M 0.37%
+690,000
New +$16.4M
JAH
59
DELISTED
JARDEN CORPORATION
JAH
$18M 0.35%
441,011
+162,057
+58% +$5.88M
DHR icon
60
Danaher
DHR
$140B
$17.8M 0.35%
343,886
-232,247
-40% -$11.4M
BAX icon
61
Baxter International
BAX
$12.7B
$17.5M 0.34%
462,432
+122,353
+36% +$4.44M
SRPT icon
62
Sarepta Therapeutics
SRPT
$1.65B
$17.3M 0.34%
+850,400
New +$25.3M
ELV icon
63
Elevance Health
ELV
$82B
$16.2M 0.32%
175,020
-91,130
-34% -$8.1M
DOC icon
64
Healthpeak Properties
DOC
$15.6B
$15.3M 0.3%
463,842
-725,360
-61% -$25.9M
ILMN icon
65
Illumina
ILMN
$29.1B
$14.9M 0.29%
+138,212
New +$12.7M
ALR
66
DELISTED
Alere Inc
ALR
$14.8M 0.29%
+408,585
New +$13.6M
DTE icon
67
DTE Energy
DTE
$30.1B
$14.7M 0.29%
259,474
+230,393
+792% +$13.2M
RTX icon
68
RTX Corp
RTX
$295B
$14.5M 0.29%
202,761
+133,400
+192% +$9.09M
SCMP
69
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$14.1M 0.28%
+1,500,000
New +$10.7M
CMS icon
70
CMS Energy
CMS
$23.1B
$14M 0.28%
524,716
+246,766
+89% +$6.64M
HTWR
71
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$13.8M 0.27%
+147,333
New +$12.5M
CYH icon
72
Community Health Systems
CYH
$384M
$13.5M 0.26%
415,103
+403,850
+3,589% +$13.9M
INFI
73
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$13.1M 0.26%
+951,852
New +$13.4M
ISRG icon
74
Intuitive Surgical
ISRG
$127B
$13.1M 0.26%
307,899
-243,711
-44% -$10.3M
FURX
75
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$13.1M 0.26%
+312,698
New +$12.9M
1 2
3
4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, Visium Asset Management held 1,104 positions worth $5.09B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Visium Asset Management deployed $313M of net new capital in Q4 2013, opening 355 new positions and adding to 287 existing holdings. Its largest new stake was Bausch Health: 766,970 shares worth $90M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Perrigo, an estimated $122M trimmed.

  • Visium Asset Management's largest Q4 2013 buy was Bausch Health: 766,970 shares worth $90M.
  • Visium Asset Management added most to Allergan plc in Q4 2013, an estimated $115M increase.
  • Visium Asset Management's biggest Q4 2013 reduction was Perrigo, cutting an estimated $122M.
  • Visium Asset Management fully exited WARNER CHILCOTT PLC ORD SHS CL A (IRL) in Q4 2013, selling an estimated $160M.
  • Visium Asset Management's ten largest holdings make up 29% of its $5.09B portfolio in Q4 2013.
  • Visium Asset Management opened 355 new positions and closed 246 in Q4 2013.
  • Visium Asset Management's portfolio value rose 16% quarter-over-quarter to $5.09B.

Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.